Prostacycline [EPC]

Known as: Prostacycline, Prostacycline-class Agent 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1977-2017
0519772017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
In the current study, vasorelaxant effect produced by the aqueous extract of Melissa officinalis L. ssp. officinalis (MOO… (More)
Is this relevant?
2008
2008
OBJECTIVE To assess the clinical and radiographic features of hand involvement in patients with systemic sclerosis (SSc… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2003
2003
Aerosolized iloprost is now used as a therapeutic option in the treatment of pulmonary hypertension. We report on the… (More)
Is this relevant?
2003
2003
INTRODUCTION Aspirin decreases the activity of iNOS and the formation of prostanoids. Constitutive nitric oxide synthase (cNOS… (More)
Is this relevant?
2001
2001
Combined acute inhibition of the synthesis of nitric oxide with L-nitroarginine methyl ester (L-NAME) and of prostacycline… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1999
1999
This study aims to evaluate the reliability of repeated graded workload treadmill testing (G-test; 2 mph; 0% grade, increasing 2… (More)
Is this relevant?
1997
1997
OBJECTIVE To investigate the effect of iloprost, a stable prostacycline analog, on kidney blood flow in patients with systemic… (More)
Is this relevant?
1995
1995
We induced an essential fatty acid deficiency (EFAD) in human umbilical vein endothelial cells by culture in medium with 20% (vol… (More)
Is this relevant?
1993
1993
The pathophysiological mechanisms to explain peritumoral edema have not been clarified. Multiple aspects of brain edema secondary… (More)
Is this relevant?
1986
1986
Antibodies that bind to human platelet membrane glycoproteins IIb and IIIa were used to develop methods for analyzing platelet… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 7
Is this relevant?